Study an microbial persistence in end-stage idiopathic dilated cardiomyopathy

被引:13
|
作者
de Leeuw, N
Melchers, WJG
Balk, AHMM
de Jonge, N
Galama, JMD
机构
[1] Univ Nijmegen Hosp, Dept Med Microbiol, NL-6500 HB Nijmegen, Netherlands
[2] Univ Hosp Rotterdam Dijkzigt, Dept Cardiol, Rotterdam, Netherlands
[3] Univ Utrecht Hosp, Dept Cardiol, Utrecht, Netherlands
关键词
D O I
10.1086/598625
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Microbial persistence may be involved in the pathogenesis of idiopathic dilated cardiomyopathy (IDC). Therefore, we evaluated the role of various cardiopathogenic microorganisms in patients with end-stage IDC. In a previous study, we did not find evidence for the persistence of enterovirus RNA in end-stage IDC. In the present study, we looked for other microorganisms that are frequently associated with heart disease, including cytomegalovirus, hepatitis B virus,hepatitis C virus, Borrelia burgdorferi, Chlamydia species, mycoplasmata, and Toxoplasma gondii. Serology, polymerase chain reaction (PCR) analysis specific for detection of microbial genomic sequences, or both investigations were performed on myocardial samples from 37 patients with end-stage IDC. PCR analysis was performed on multiple myocardial samples per patient Thirty-nine patients with end-stage heart disease of known cause were included as controls. On the basis of our serological data and PCR analyses, we did not find any evidence that microbial persistence in the heart is involved in the end-stage disease process of IDC.
引用
收藏
页码:522 / 525
页数:4
相关论文
共 50 条
  • [41] The apelin/APJ mRNA profile in left ventricular tissue of patients with idiopathic or ischemic end-stage dilated cardiomyopathy
    Cabiati, M.
    Svezia, B.
    Botta, L.
    Cesare, M. M.
    Caselli, C.
    Matteucci, M.
    Lionetti, V.
    Del Ry, S.
    EUROPEAN HEART JOURNAL, 2016, 37 : 532 - 532
  • [42] Gene expression profiles in end-stage human idiopathic dilated cardiomyopathy: altered expression of apoptotic and cytoskeletal genes
    Yung, CK
    Halperin, VL
    Tomaselli, GF
    Winslow, RL
    GENOMICS, 2004, 83 (02) : 281 - 297
  • [43] HLA antigen frequencies in end-stage idiopathic and ischaemic cardiomyopathy
    Harcombe, AA
    Sharples, L
    Large, SR
    Wallwork, J
    Weissberg, PL
    Joysey, V
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 1999, 68 (01) : 31 - 37
  • [44] LONG-TERM EFFICACY OF PHYSIOLOGICAL DUAL-CHAMBER PACING IN THE TREATMENT OF END-STAGE IDIOPATHIC DILATED CARDIOMYOPATHY
    HOCHLEITNER, M
    HORTNAGL, H
    HORTNAGL, H
    FRIDRICH, L
    GSCHNITZER, F
    AMERICAN JOURNAL OF CARDIOLOGY, 1992, 70 (15): : 1320 - 1325
  • [45] An embolic event to death in more than 50 percent of patients with idiopathic dilated cardiomyopathy in end-stage heart failure
    Barretto, AC
    Oliveira, MT
    Oliveira, MT
    Munhoz, RT
    Scipioni, AR
    Higuchi, ML
    Ramires, JAF
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2004, 43 (05) : 197A - 198A
  • [46] Myocardial expression analysis of osteopontin and its splice variants in patients affected by end-stage idiopathic or ischemic dilated cardiomyopathy
    Cabiati, M.
    Svezia, B.
    Matteucci, M.
    Botta, L.
    Pucci, A.
    Caselli, C.
    Lionetti, V.
    Del Ry, S.
    VASCULAR PHARMACOLOGY, 2015, 75 : 43 - 43
  • [47] Myocardial capillary density is severely reduced in patients with end-stage congestive heart failure secondary to idiopathic dilated cardiomyopathy
    Tsagalou, E.
    Agapitos, E.
    Kanakakis, J.
    Alexopoulos, G.
    Ntalianis, A.
    Lazaris, N.
    Pantsios, C.
    Nanas, J.
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2008, 51 (10) : A308 - A308
  • [48] Myocardial Expression Analysis of Osteopontin and Its Splice Variants in Patients Affected by End-Stage Idiopathic or Ischemic Dilated Cardiomyopathy
    Cabiati, Manuela
    Svezia, Benedetta
    Matteucci, Marco
    Botta, Luca
    Pucci, Angela
    Rinaldi, Mauro
    Caselli, Chiara
    Lionetti, Vincenzo
    Del Ry, Silvia
    PLOS ONE, 2016, 11 (08):
  • [49] Management of dilated cardiomyopathy (DC) in children with end-stage renal disease (ESRD).
    Onder, AM
    Mas, M
    Pereira, C
    Cepero, A
    Ramirez, F
    Paredes, A
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2002, 13 : 675A - 676A
  • [50] Apoptosis of myocytes and proliferation markers as prognostic factors in end-stage dilated cardiomyopathy
    Zorc, M
    Vraspir-Porenta, O
    Zorc-Pleskovic, R
    Radovanovic, N
    Petrovic, D
    CARDIOVASCULAR PATHOLOGY, 2003, 12 (01) : 36 - 39